Based on the available data, there is no evidence that VKORC1 can help with menopause. VKORC1 encodes vitamin K epoxide reductase, primarily studied in pharmacogenetics for warfarin dosing. A direct role in menopausal symptoms (hot flashes, mood changes, sleep disturbances) is not supported. While VKORC1 influences vitamin K recycling, which affects vitamin K-dependent proteins involved in bone metabolism—potentially relevant to postmenopausal osteoporosis—this is speculative and not backed by the provided context. The knowledge snippets contain no studies, GWAS, or mechanistic links connecting VKORC1 to menopause. Consumer DNA tests making such claims should be viewed with caution. The evidence grade is 'unclear'. For menopause management, established interventions like hormone therapy, lifestyle modifications, and medical consultation are more appropriate than focusing on this gene.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-aaf57cc8f3a14c5a373d36ae